nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—uterine cancer—cervical cancer	0.881	1	CtDrD
Progesterone—ABCB1—Topotecan—cervical cancer	0.0143	0.625	CbGbCtD
Progesterone—CYP3A4—Topotecan—cervical cancer	0.00857	0.375	CbGbCtD
Progesterone—Dyspareunia—Topotecan—cervical cancer	0.00417	0.161	CcSEcCtD
Progesterone—SHBG—semen—cervical cancer	0.00381	0.0643	CbGeAlD
Progesterone—AR—semen—cervical cancer	0.00273	0.0461	CbGeAlD
Progesterone—SLC10A1—renal system—cervical cancer	0.001	0.0169	CbGeAlD
Progesterone—CYP17A1—renal system—cervical cancer	0.000872	0.0147	CbGeAlD
Progesterone—Dysmenorrhoea—Topotecan—cervical cancer	0.000838	0.0323	CcSEcCtD
Progesterone—SLC10A1—female reproductive system—cervical cancer	0.000802	0.0135	CbGeAlD
Progesterone—Bone pain—Topotecan—cervical cancer	0.000796	0.0307	CcSEcCtD
Progesterone—SLC22A2—renal system—cervical cancer	0.000794	0.0134	CbGeAlD
Progesterone—Pulmonary embolism—Topotecan—cervical cancer	0.000762	0.0294	CcSEcCtD
Progesterone—OPRK1—female reproductive system—cervical cancer	0.000706	0.0119	CbGeAlD
Progesterone—CYP17A1—female reproductive system—cervical cancer	0.000698	0.0118	CbGeAlD
Progesterone—Neoplasm—Topotecan—cervical cancer	0.000689	0.0266	CcSEcCtD
Progesterone—NR3C2—uterine cervix—cervical cancer	0.000673	0.0114	CbGeAlD
Progesterone—Ear pain—Topotecan—cervical cancer	0.000649	0.025	CcSEcCtD
Progesterone—CYP17A1—female gonad—cervical cancer	0.000635	0.0107	CbGeAlD
Progesterone—PGR—epithelium—cervical cancer	0.000631	0.0107	CbGeAlD
Progesterone—NR3C2—renal system—cervical cancer	0.00063	0.0106	CbGeAlD
Progesterone—SHBG—endometrium—cervical cancer	0.000629	0.0106	CbGeAlD
Progesterone—PGR—uterine cervix—cervical cancer	0.000626	0.0106	CbGeAlD
Progesterone—NR3C2—endometrium—cervical cancer	0.000609	0.0103	CbGeAlD
Progesterone—PGR—decidua—cervical cancer	0.000596	0.0101	CbGeAlD
Progesterone—NR3C2—mammalian vulva—cervical cancer	0.000589	0.00995	CbGeAlD
Progesterone—SHBG—uterus—cervical cancer	0.000579	0.00978	CbGeAlD
Progesterone—SLC22A3—uterine cervix—cervical cancer	0.000573	0.00968	CbGeAlD
Progesterone—Anaphylactoid reaction—Topotecan—cervical cancer	0.000572	0.022	CcSEcCtD
Progesterone—PGR—endometrium—cervical cancer	0.000566	0.00956	CbGeAlD
Progesterone—NR3C2—uterus—cervical cancer	0.000561	0.00948	CbGeAlD
Progesterone—SLC22A1—renal system—cervical cancer	0.000561	0.00947	CbGeAlD
Progesterone—SIGMAR1—uterine cervix—cervical cancer	0.000554	0.00935	CbGeAlD
Progesterone—SLC22A3—renal system—cervical cancer	0.000536	0.00905	CbGeAlD
Progesterone—SIGMAR1—decidua—cervical cancer	0.000528	0.00891	CbGeAlD
Progesterone—PGR—uterus—cervical cancer	0.000522	0.00881	CbGeAlD
Progesterone—SHBG—female reproductive system—cervical cancer	0.000521	0.00879	CbGeAlD
Progesterone—SLC22A3—endometrium—cervical cancer	0.000518	0.00875	CbGeAlD
Progesterone—NR3C2—female reproductive system—cervical cancer	0.000505	0.00852	CbGeAlD
Progesterone—AR—epithelium—cervical cancer	0.000503	0.0085	CbGeAlD
Progesterone—CYP1B1—decidua—cervical cancer	0.000502	0.00847	CbGeAlD
Progesterone—SLC22A3—mammalian vulva—cervical cancer	0.000501	0.00847	CbGeAlD
Progesterone—SIGMAR1—endometrium—cervical cancer	0.000501	0.00846	CbGeAlD
Progesterone—AR—uterine cervix—cervical cancer	0.000499	0.00842	CbGeAlD
Progesterone—Cramp muscle—Topotecan—cervical cancer	0.000498	0.0192	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Topotecan—cervical cancer	0.000498	0.0192	CcSEcCtD
Progesterone—ESR1—epithelium—cervical cancer	0.000494	0.00834	CbGeAlD
Progesterone—CYP1B1—renal system—cervical cancer	0.000493	0.00832	CbGeAlD
Progesterone—ESR1—uterine cervix—cervical cancer	0.00049	0.00827	CbGeAlD
Progesterone—Alanine aminotransferase increased—Topotecan—cervical cancer	0.000488	0.0188	CcSEcCtD
Progesterone—CYP2A6—vagina—cervical cancer	0.000487	0.00822	CbGeAlD
Progesterone—SIGMAR1—mammalian vulva—cervical cancer	0.000485	0.00818	CbGeAlD
Progesterone—AR—decidua—cervical cancer	0.000475	0.00803	CbGeAlD
Progesterone—SHBG—female gonad—cervical cancer	0.000474	0.008	CbGeAlD
Progesterone—ABCC1—uterine cervix—cervical cancer	0.000474	0.008	CbGeAlD
Progesterone—SHBG—vagina—cervical cancer	0.000471	0.00795	CbGeAlD
Progesterone—PGR—female reproductive system—cervical cancer	0.000469	0.00792	CbGeAlD
Progesterone—AR—renal system—cervical cancer	0.000467	0.00788	CbGeAlD
Progesterone—ESR1—decidua—cervical cancer	0.000466	0.00788	CbGeAlD
Progesterone—SIGMAR1—uterus—cervical cancer	0.000462	0.0078	CbGeAlD
Progesterone—NR3C2—female gonad—cervical cancer	0.000459	0.00775	CbGeAlD
Progesterone—ESR1—renal system—cervical cancer	0.000458	0.00774	CbGeAlD
Progesterone—NR3C2—vagina—cervical cancer	0.000456	0.00771	CbGeAlD
Progesterone—ABCC1—decidua—cervical cancer	0.000451	0.00762	CbGeAlD
Progesterone—AR—endometrium—cervical cancer	0.000451	0.00762	CbGeAlD
Progesterone—ESR1—endometrium—cervical cancer	0.000443	0.00748	CbGeAlD
Progesterone—CYP1B1—uterus—cervical cancer	0.000439	0.00741	CbGeAlD
Progesterone—AR—mammalian vulva—cervical cancer	0.000436	0.00737	CbGeAlD
Progesterone—Weight increased—Topotecan—cervical cancer	0.000435	0.0168	CcSEcCtD
Progesterone—SLC22A3—female reproductive system—cervical cancer	0.000429	0.00725	CbGeAlD
Progesterone—Pneumonia—Topotecan—cervical cancer	0.000429	0.0165	CcSEcCtD
Progesterone—ABCC1—endometrium—cervical cancer	0.000428	0.00724	CbGeAlD
Progesterone—PGR—female gonad—cervical cancer	0.000427	0.00721	CbGeAlD
Progesterone—Infestation NOS—Topotecan—cervical cancer	0.000427	0.0164	CcSEcCtD
Progesterone—Infestation—Topotecan—cervical cancer	0.000427	0.0164	CcSEcCtD
Progesterone—PGR—vagina—cervical cancer	0.000424	0.00716	CbGeAlD
Progesterone—Neuropathy peripheral—Topotecan—cervical cancer	0.000418	0.0161	CcSEcCtD
Progesterone—AR—uterus—cervical cancer	0.000416	0.00702	CbGeAlD
Progesterone—ABCC1—mammalian vulva—cervical cancer	0.000414	0.007	CbGeAlD
Progesterone—CYP17A1—lymph node—cervical cancer	0.000409	0.0069	CbGeAlD
Progesterone—ESR1—uterus—cervical cancer	0.000408	0.00689	CbGeAlD
Progesterone—SLC22A1—vagina—cervical cancer	0.000406	0.00686	CbGeAlD
Progesterone—Hepatobiliary disease—Topotecan—cervical cancer	0.000403	0.0155	CcSEcCtD
Progesterone—ABCC1—uterus—cervical cancer	0.000395	0.00667	CbGeAlD
Progesterone—CYP1B1—female reproductive system—cervical cancer	0.000395	0.00666	CbGeAlD
Progesterone—SLC22A3—female gonad—cervical cancer	0.000391	0.0066	CbGeAlD
Progesterone—SLC22A3—vagina—cervical cancer	0.000388	0.00656	CbGeAlD
Progesterone—Haemoglobin—Topotecan—cervical cancer	0.000385	0.0148	CcSEcCtD
Progesterone—Rhinitis—Topotecan—cervical cancer	0.000384	0.0148	CcSEcCtD
Progesterone—Haemorrhage—Topotecan—cervical cancer	0.000383	0.0148	CcSEcCtD
Progesterone—Pharyngitis—Topotecan—cervical cancer	0.00038	0.0146	CcSEcCtD
Progesterone—SIGMAR1—female gonad—cervical cancer	0.000378	0.00638	CbGeAlD
Progesterone—CYP2C8—renal system—cervical cancer	0.000377	0.00637	CbGeAlD
Progesterone—CYP1A1—epithelium—cervical cancer	0.000376	0.00634	CbGeAlD
Progesterone—SIGMAR1—vagina—cervical cancer	0.000375	0.00634	CbGeAlD
Progesterone—AR—female reproductive system—cervical cancer	0.000374	0.00631	CbGeAlD
Progesterone—CYP1A1—uterine cervix—cervical cancer	0.000372	0.00629	CbGeAlD
Progesterone—ESR1—female reproductive system—cervical cancer	0.000367	0.0062	CbGeAlD
Progesterone—CYP2C8—endometrium—cervical cancer	0.000365	0.00616	CbGeAlD
Progesterone—NR3C1—epithelium—cervical cancer	0.000364	0.00615	CbGeAlD
Progesterone—CYP3A5—uterine cervix—cervical cancer	0.000364	0.00615	CbGeAlD
Progesterone—NR3C1—uterine cervix—cervical cancer	0.000361	0.0061	CbGeAlD
Progesterone—CYP1B1—female gonad—cervical cancer	0.000359	0.00606	CbGeAlD
Progesterone—CYP1A2—renal system—cervical cancer	0.000353	0.00596	CbGeAlD
Progesterone—CYP1A1—renal system—cervical cancer	0.000348	0.00588	CbGeAlD
Progesterone—Angiopathy—Topotecan—cervical cancer	0.000347	0.0134	CcSEcCtD
Progesterone—Immune system disorder—Topotecan—cervical cancer	0.000346	0.0133	CcSEcCtD
Progesterone—Mediastinal disorder—Topotecan—cervical cancer	0.000345	0.0133	CcSEcCtD
Progesterone—NR3C1—decidua—cervical cancer	0.000344	0.00581	CbGeAlD
Progesterone—CYP3A5—renal system—cervical cancer	0.000341	0.00575	CbGeAlD
Progesterone—AR—female gonad—cervical cancer	0.00034	0.00574	CbGeAlD
Progesterone—Alopecia—Topotecan—cervical cancer	0.000338	0.013	CcSEcCtD
Progesterone—AR—vagina—cervical cancer	0.000338	0.00571	CbGeAlD
Progesterone—NR3C1—renal system—cervical cancer	0.000338	0.00571	CbGeAlD
Progesterone—ESR1—female gonad—cervical cancer	0.000334	0.00564	CbGeAlD
Progesterone—Malnutrition—Topotecan—cervical cancer	0.000333	0.0128	CcSEcCtD
Progesterone—ESR1—vagina—cervical cancer	0.000332	0.0056	CbGeAlD
Progesterone—NR3C1—endometrium—cervical cancer	0.000327	0.00552	CbGeAlD
Progesterone—CYP1A1—mammalian vulva—cervical cancer	0.000326	0.0055	CbGeAlD
Progesterone—ABCC1—female gonad—cervical cancer	0.000323	0.00545	CbGeAlD
Progesterone—Back pain—Topotecan—cervical cancer	0.000322	0.0124	CcSEcCtD
Progesterone—ABCC1—vagina—cervical cancer	0.000321	0.00542	CbGeAlD
Progesterone—Muscle spasms—Topotecan—cervical cancer	0.00032	0.0123	CcSEcCtD
Progesterone—NR3C1—mammalian vulva—cervical cancer	0.000316	0.00534	CbGeAlD
Progesterone—CYP2C19—vagina—cervical cancer	0.000313	0.00529	CbGeAlD
Progesterone—CYP1A1—uterus—cervical cancer	0.00031	0.00524	CbGeAlD
Progesterone—Ill-defined disorder—Topotecan—cervical cancer	0.000309	0.0119	CcSEcCtD
Progesterone—Anaemia—Topotecan—cervical cancer	0.000308	0.0119	CcSEcCtD
Progesterone—Angioedema—Topotecan—cervical cancer	0.000305	0.0117	CcSEcCtD
Progesterone—CYP2C8—female reproductive system—cervical cancer	0.000302	0.0051	CbGeAlD
Progesterone—NR3C1—uterus—cervical cancer	0.000301	0.00508	CbGeAlD
Progesterone—Malaise—Topotecan—cervical cancer	0.000301	0.0116	CcSEcCtD
Progesterone—NR3C2—lymph node—cervical cancer	0.000295	0.00498	CbGeAlD
Progesterone—Cough—Topotecan—cervical cancer	0.000291	0.0112	CcSEcCtD
Progesterone—Chest pain—Topotecan—cervical cancer	0.000284	0.0109	CcSEcCtD
Progesterone—Arthralgia—Topotecan—cervical cancer	0.000284	0.0109	CcSEcCtD
Progesterone—Myalgia—Topotecan—cervical cancer	0.000284	0.0109	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Topotecan—cervical cancer	0.000282	0.0109	CcSEcCtD
Progesterone—Discomfort—Topotecan—cervical cancer	0.00028	0.0108	CcSEcCtD
Progesterone—CYP1A1—female reproductive system—cervical cancer	0.000279	0.00471	CbGeAlD
Progesterone—PGR—lymph node—cervical cancer	0.000274	0.00463	CbGeAlD
Progesterone—CYP2C8—vagina—cervical cancer	0.000273	0.00462	CbGeAlD
Progesterone—Anaphylactic shock—Topotecan—cervical cancer	0.000272	0.0105	CcSEcCtD
Progesterone—NR3C1—female reproductive system—cervical cancer	0.000271	0.00457	CbGeAlD
Progesterone—Infection—Topotecan—cervical cancer	0.00027	0.0104	CcSEcCtD
Progesterone—CYP2C9—female reproductive system—cervical cancer	0.000268	0.00453	CbGeAlD
Progesterone—Nervous system disorder—Topotecan—cervical cancer	0.000267	0.0103	CcSEcCtD
Progesterone—Skin disorder—Topotecan—cervical cancer	0.000264	0.0102	CcSEcCtD
Progesterone—Hyperhidrosis—Topotecan—cervical cancer	0.000263	0.0101	CcSEcCtD
Progesterone—Anorexia—Topotecan—cervical cancer	0.000259	0.00999	CcSEcCtD
Progesterone—CYP3A4—renal system—cervical cancer	0.000256	0.00432	CbGeAlD
Progesterone—CYP1A1—female gonad—cervical cancer	0.000254	0.00429	CbGeAlD
Progesterone—CYP1A1—vagina—cervical cancer	0.000252	0.00426	CbGeAlD
Progesterone—CYP2D6—renal system—cervical cancer	0.000252	0.00425	CbGeAlD
Progesterone—SLC22A3—lymph node—cervical cancer	0.000251	0.00424	CbGeAlD
Progesterone—CYP3A5—female gonad—cervical cancer	0.000248	0.00419	CbGeAlD
Progesterone—Musculoskeletal discomfort—Topotecan—cervical cancer	0.000248	0.00955	CcSEcCtD
Progesterone—CYP3A5—vagina—cervical cancer	0.000247	0.00417	CbGeAlD
Progesterone—NR3C1—female gonad—cervical cancer	0.000246	0.00416	CbGeAlD
Progesterone—NR3C1—vagina—cervical cancer	0.000245	0.00413	CbGeAlD
Progesterone—Paraesthesia—Topotecan—cervical cancer	0.000244	0.00941	CcSEcCtD
Progesterone—SIGMAR1—lymph node—cervical cancer	0.000243	0.0041	CbGeAlD
Progesterone—Dyspnoea—Topotecan—cervical cancer	0.000243	0.00935	CcSEcCtD
Progesterone—Dyspepsia—Topotecan—cervical cancer	0.000239	0.00923	CcSEcCtD
Progesterone—Decreased appetite—Topotecan—cervical cancer	0.000236	0.00911	CcSEcCtD
Progesterone—Gastrointestinal disorder—Topotecan—cervical cancer	0.000235	0.00905	CcSEcCtD
Progesterone—Fatigue—Topotecan—cervical cancer	0.000235	0.00904	CcSEcCtD
Progesterone—Constipation—Topotecan—cervical cancer	0.000233	0.00896	CcSEcCtD
Progesterone—Pain—Topotecan—cervical cancer	0.000233	0.00896	CcSEcCtD
Progesterone—CYP1B1—lymph node—cervical cancer	0.000231	0.0039	CbGeAlD
Progesterone—AR—Androgen receptor signaling pathway—PIAS3—cervical cancer	0.000227	0.0209	CbGpPWpGaD
Progesterone—Feeling abnormal—Topotecan—cervical cancer	0.000224	0.00864	CcSEcCtD
Progesterone—Gastrointestinal pain—Topotecan—cervical cancer	0.000222	0.00857	CcSEcCtD
Progesterone—AR—lymph node—cervical cancer	0.000219	0.00369	CbGeAlD
Progesterone—Urticaria—Topotecan—cervical cancer	0.000216	0.00833	CcSEcCtD
Progesterone—Abdominal pain—Topotecan—cervical cancer	0.000215	0.00829	CcSEcCtD
Progesterone—Body temperature increased—Topotecan—cervical cancer	0.000215	0.00829	CcSEcCtD
Progesterone—ESR1—lymph node—cervical cancer	0.000215	0.00362	CbGeAlD
Progesterone—ABCC1—lymph node—cervical cancer	0.000208	0.00351	CbGeAlD
Progesterone—CYP1B1—Tryptophan metabolism—UBE3A—cervical cancer	0.000206	0.0189	CbGpPWpGaD
Progesterone—CYP3A4—female reproductive system—cervical cancer	0.000205	0.00346	CbGeAlD
Progesterone—CYP2D6—female reproductive system—cervical cancer	0.000201	0.0034	CbGeAlD
Progesterone—Hypersensitivity—Topotecan—cervical cancer	0.0002	0.00772	CcSEcCtD
Progesterone—AR—Coregulation of Androgen receptor activity—UBE3A—cervical cancer	0.000198	0.0182	CbGpPWpGaD
Progesterone—Asthenia—Topotecan—cervical cancer	0.000195	0.00752	CcSEcCtD
Progesterone—ABCB1—epithelium—cervical cancer	0.000195	0.00329	CbGeAlD
Progesterone—ABCB1—uterine cervix—cervical cancer	0.000193	0.00327	CbGeAlD
Progesterone—Pruritus—Topotecan—cervical cancer	0.000192	0.00742	CcSEcCtD
Progesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—PIAS3—cervical cancer	0.000189	0.0174	CbGpPWpGaD
Progesterone—AR—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.000186	0.0171	CbGpPWpGaD
Progesterone—Diarrhoea—Topotecan—cervical cancer	0.000186	0.00717	CcSEcCtD
Progesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—PIAS3—cervical cancer	0.000186	0.0171	CbGpPWpGaD
Progesterone—ABCB1—decidua—cervical cancer	0.000184	0.00311	CbGeAlD
Progesterone—CYP2D6—female gonad—cervical cancer	0.000183	0.0031	CbGeAlD
Progesterone—ESR1—Nuclear Receptors—RARB—cervical cancer	0.000182	0.0167	CbGpPWpGaD
Progesterone—ABCB1—renal system—cervical cancer	0.000181	0.00306	CbGeAlD
Progesterone—Dizziness—Topotecan—cervical cancer	0.00018	0.00693	CcSEcCtD
Progesterone—NR3C1—Nuclear Receptors—RARB—cervical cancer	0.000179	0.0165	CbGpPWpGaD
Progesterone—ABCB1—endometrium—cervical cancer	0.000175	0.00295	CbGeAlD
Progesterone—Vomiting—Topotecan—cervical cancer	0.000173	0.00666	CcSEcCtD
Progesterone—Rash—Topotecan—cervical cancer	0.000172	0.00661	CcSEcCtD
Progesterone—Dermatitis—Topotecan—cervical cancer	0.000171	0.0066	CcSEcCtD
Progesterone—Headache—Topotecan—cervical cancer	0.00017	0.00657	CcSEcCtD
Progesterone—ABCB1—mammalian vulva—cervical cancer	0.000169	0.00286	CbGeAlD
Progesterone—CYP1A1—lymph node—cervical cancer	0.000163	0.00276	CbGeAlD
Progesterone—Nausea—Topotecan—cervical cancer	0.000162	0.00623	CcSEcCtD
Progesterone—ABCB1—uterus—cervical cancer	0.000161	0.00272	CbGeAlD
Progesterone—NR3C1—lymph node—cervical cancer	0.000158	0.00267	CbGeAlD
Progesterone—AR—Androgen receptor signaling pathway—UBE3A—cervical cancer	0.000146	0.0135	CbGpPWpGaD
Progesterone—ABCB1—female reproductive system—cervical cancer	0.000145	0.00245	CbGeAlD
Progesterone—ESR1—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.000143	0.0132	CbGpPWpGaD
Progesterone—NR3C1—Nuclear Receptor transcription pathway—RARB—cervical cancer	0.000141	0.013	CbGpPWpGaD
Progesterone—ESR1—Regulation of Telomerase—UBE3A—cervical cancer	0.00014	0.0129	CbGpPWpGaD
Progesterone—ABCB1—female gonad—cervical cancer	0.000132	0.00223	CbGeAlD
Progesterone—ABCB1—vagina—cervical cancer	0.000131	0.00221	CbGeAlD
Progesterone—CYP1A1—Tryptophan metabolism—UBE3A—cervical cancer	0.000127	0.0117	CbGpPWpGaD
Progesterone—CYP2A6—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000123	0.0113	CbGpPWpGaD
Progesterone—CYP1B1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000109	0.0101	CbGpPWpGaD
Progesterone—AR—Notch-mediated HES/HEY network—HES1—cervical cancer	0.000108	0.00994	CbGpPWpGaD
Progesterone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000105	0.00966	CbGpPWpGaD
Progesterone—ESR1—Estrogen Receptor Pathway—STAT3—cervical cancer	0.000102	0.00936	CbGpPWpGaD
Progesterone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	9.81e-05	0.00903	CbGpPWpGaD
Progesterone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	9.1e-05	0.00838	CbGpPWpGaD
Progesterone—CYP2A6—Fluoropyrimidine Activity—MTHFR—cervical cancer	8.62e-05	0.00794	CbGpPWpGaD
Progesterone—ABCB1—lymph node—cervical cancer	8.48e-05	0.00143	CbGeAlD
Progesterone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	8.38e-05	0.00771	CbGpPWpGaD
Progesterone—AR—Notch-mediated HES/HEY network—NOTCH1—cervical cancer	8.15e-05	0.0075	CbGpPWpGaD
Progesterone—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	8.07e-05	0.00743	CbGpPWpGaD
Progesterone—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	7.26e-05	0.00668	CbGpPWpGaD
Progesterone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	7.15e-05	0.00658	CbGpPWpGaD
Progesterone—ESR1—ATF-2 transcription factor network—HES1—cervical cancer	6.93e-05	0.00638	CbGpPWpGaD
Progesterone—NR3C2—Generic Transcription Pathway—RARB—cervical cancer	6.93e-05	0.00638	CbGpPWpGaD
Progesterone—CYP1A1—Estrogen Receptor Pathway—STAT3—cervical cancer	6.73e-05	0.0062	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	6.47e-05	0.00596	CbGpPWpGaD
Progesterone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	6.47e-05	0.00595	CbGpPWpGaD
Progesterone—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	6.23e-05	0.00573	CbGpPWpGaD
Progesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—cervical cancer	6.18e-05	0.00569	CbGpPWpGaD
Progesterone—AR—Notch-mediated HES/HEY network—CD4—cervical cancer	6.1e-05	0.00561	CbGpPWpGaD
Progesterone—AR—Coregulation of Androgen receptor activity—CASP8—cervical cancer	6.03e-05	0.00555	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	5.6e-05	0.00516	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—TAAR6—cervical cancer	5.45e-05	0.00501	CbGpPWpGaD
Progesterone—ESR1—Regulation of Telomerase—TERT—cervical cancer	5.42e-05	0.00499	CbGpPWpGaD
Progesterone—ESR1—LKB1 signaling events—MTOR—cervical cancer	5.05e-05	0.00465	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	4.99e-05	0.00459	CbGpPWpGaD
Progesterone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	4.97e-05	0.00457	CbGpPWpGaD
Progesterone—AR—Notch-mediated HES/HEY network—STAT3—cervical cancer	4.72e-05	0.00434	CbGpPWpGaD
Progesterone—NR3C1—Endoderm Differentiation—NOTCH1—cervical cancer	4.6e-05	0.00424	CbGpPWpGaD
Progesterone—NR3C2—Generic Transcription Pathway—NOTCH2—cervical cancer	4.59e-05	0.00423	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—FGFR3—cervical cancer	4.46e-05	0.0041	CbGpPWpGaD
Progesterone—AR—Coregulation of Androgen receptor activity—CTNNB1—cervical cancer	4.4e-05	0.00405	CbGpPWpGaD
Progesterone—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	4.29e-05	0.00395	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—WNT2—cervical cancer	4.25e-05	0.00391	CbGpPWpGaD
Progesterone—PGR—Generic Transcription Pathway—RARB—cervical cancer	4.22e-05	0.00389	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—HES1—cervical cancer	4.13e-05	0.00381	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	3.92e-05	0.00361	CbGpPWpGaD
Progesterone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	3.62e-05	0.00333	CbGpPWpGaD
Progesterone—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	3.62e-05	0.00333	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	3.57e-05	0.00329	CbGpPWpGaD
Progesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—cervical cancer	3.54e-05	0.00326	CbGpPWpGaD
Progesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	3.51e-05	0.00323	CbGpPWpGaD
Progesterone—ESR1—Regulation of Telomerase—MTOR—cervical cancer	3.5e-05	0.00322	CbGpPWpGaD
Progesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	3.36e-05	0.00309	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—RARB—cervical cancer	3.34e-05	0.00307	CbGpPWpGaD
Progesterone—CYP2A6—Fluoropyrimidine Activity—TP53—cervical cancer	3.27e-05	0.00301	CbGpPWpGaD
Progesterone—AR—Androgen receptor signaling pathway—CTNNB1—cervical cancer	3.25e-05	0.00299	CbGpPWpGaD
Progesterone—ESR1—Leptin signaling pathway—MTOR—cervical cancer	3.24e-05	0.00298	CbGpPWpGaD
Progesterone—OPRK1—GPCR ligand binding—WNT5A—cervical cancer	3.22e-05	0.00297	CbGpPWpGaD
Progesterone—AR—Generic Transcription Pathway—RARB—cervical cancer	3.22e-05	0.00296	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—HES1—cervical cancer	3.14e-05	0.00289	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—MTOR—cervical cancer	3.13e-05	0.00289	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—TAAR6—cervical cancer	3.08e-05	0.00283	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	3.06e-05	0.00281	CbGpPWpGaD
Progesterone—NR3C1—Endoderm Differentiation—CTNNB1—cervical cancer	3.06e-05	0.00281	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—CTNNB1—cervical cancer	3.03e-05	0.00279	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—CTNNB1—cervical cancer	2.99e-05	0.00275	CbGpPWpGaD
Progesterone—ESR1—LKB1 signaling events—TP53—cervical cancer	2.98e-05	0.00274	CbGpPWpGaD
Progesterone—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	2.94e-05	0.00271	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—CASP8—cervical cancer	2.92e-05	0.00269	CbGpPWpGaD
Progesterone—NR3C2—Generic Transcription Pathway—NOTCH1—cervical cancer	2.84e-05	0.00262	CbGpPWpGaD
Progesterone—AR—Androgen receptor signaling pathway—STAT3—cervical cancer	2.83e-05	0.00261	CbGpPWpGaD
Progesterone—PGR—Generic Transcription Pathway—NOTCH2—cervical cancer	2.8e-05	0.00257	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—TAAR6—cervical cancer	2.79e-05	0.00257	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—CA9—cervical cancer	2.74e-05	0.00252	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	2.64e-05	0.00243	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—FGFR3—cervical cancer	2.61e-05	0.00241	CbGpPWpGaD
Progesterone—AR—Androgen receptor signaling pathway—EGFR—cervical cancer	2.57e-05	0.00237	CbGpPWpGaD
Progesterone—ESR1—Leptin signaling pathway—STAT3—cervical cancer	2.5e-05	0.0023	CbGpPWpGaD
Progesterone—ESR1—Generic Transcription Pathway—RARB—cervical cancer	2.48e-05	0.00228	CbGpPWpGaD
Progesterone—ESR1—Regulation of Telomerase—EGFR—cervical cancer	2.46e-05	0.00226	CbGpPWpGaD
Progesterone—NR3C1—Generic Transcription Pathway—RARB—cervical cancer	2.44e-05	0.00225	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	2.42e-05	0.00223	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—MTOR—cervical cancer	2.4e-05	0.00221	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—CASP8—cervical cancer	2.25e-05	0.00207	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	2.23e-05	0.00205	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	2.23e-05	0.00205	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—NOTCH2—cervical cancer	2.21e-05	0.00203	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—CASP3—cervical cancer	2.21e-05	0.00203	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—EGFR—cervical cancer	2.2e-05	0.00203	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—WNT2—cervical cancer	2.18e-05	0.00201	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—CASP3—cervical cancer	2.15e-05	0.00198	CbGpPWpGaD
Progesterone—AR—Generic Transcription Pathway—NOTCH2—cervical cancer	2.13e-05	0.00196	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	2.13e-05	0.00196	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—AKAP13—cervical cancer	2.11e-05	0.00194	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TAAR6—cervical cancer	2.11e-05	0.00194	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	2.07e-05	0.00191	CbGpPWpGaD
Progesterone—PGR—Gene Expression—RARB—cervical cancer	2.03e-05	0.00187	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—TP53—cervical cancer	2.02e-05	0.00186	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—CA9—cervical cancer	2.01e-05	0.00185	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—CASP8—cervical cancer	2e-05	0.00184	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—TP53—cervical cancer	1.99e-05	0.00183	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—AKAP13—cervical cancer	1.92e-05	0.00176	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	1.86e-05	0.00171	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—MTOR—cervical cancer	1.85e-05	0.0017	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—MTOR—cervical cancer	1.84e-05	0.00169	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	1.83e-05	0.00168	CbGpPWpGaD
Progesterone—NR3C1—Adipogenesis—CTNNB1—cervical cancer	1.82e-05	0.00168	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	1.76e-05	0.00162	CbGpPWpGaD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—cervical cancer	1.75e-05	0.00161	CbGpPWpGaD
Progesterone—PGR—Generic Transcription Pathway—NOTCH1—cervical cancer	1.73e-05	0.00159	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—CASP3—cervical cancer	1.7e-05	0.00157	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—EGFR—cervical cancer	1.69e-05	0.00155	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—CA9—cervical cancer	1.68e-05	0.00155	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—WNT5A—cervical cancer	1.65e-05	0.00152	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TAAR6—cervical cancer	1.65e-05	0.00152	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—WNT2—cervical cancer	1.65e-05	0.00151	CbGpPWpGaD
Progesterone—ESR1—Generic Transcription Pathway—NOTCH2—cervical cancer	1.64e-05	0.00151	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—CTNNB1—cervical cancer	1.64e-05	0.00151	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—CASP3—cervical cancer	1.63e-05	0.0015	CbGpPWpGaD
Progesterone—NR3C1—Generic Transcription Pathway—NOTCH2—cervical cancer	1.62e-05	0.00149	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—CA9—cervical cancer	1.61e-05	0.00149	CbGpPWpGaD
Progesterone—NR3C1—Adipogenesis—STAT3—cervical cancer	1.59e-05	0.00146	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	1.57e-05	0.00145	CbGpPWpGaD
Progesterone—AR—Gene Expression—RARB—cervical cancer	1.55e-05	0.00143	CbGpPWpGaD
Progesterone—ABCC1—Disease—WNT2—cervical cancer	1.53e-05	0.00141	CbGpPWpGaD
Progesterone—ABCB1—Allograft Rejection—CASP3—cervical cancer	1.51e-05	0.00139	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—AKAP13—cervical cancer	1.44e-05	0.00133	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	1.42e-05	0.00131	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	1.42e-05	0.00131	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—TP53—cervical cancer	1.42e-05	0.0013	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	1.41e-05	0.0013	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	1.4e-05	0.00129	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—NOTCH1—cervical cancer	1.37e-05	0.00126	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	1.36e-05	0.00125	CbGpPWpGaD
Progesterone—PGR—Gene Expression—NOTCH2—cervical cancer	1.35e-05	0.00124	CbGpPWpGaD
Progesterone—AR—Generic Transcription Pathway—NOTCH1—cervical cancer	1.32e-05	0.00121	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—cervical cancer	1.3e-05	0.0012	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—EGFR—cervical cancer	1.29e-05	0.00119	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—WNT2—cervical cancer	1.29e-05	0.00119	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—WNT5A—cervical cancer	1.25e-05	0.00115	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TAAR6—cervical cancer	1.24e-05	0.00114	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—CA9—cervical cancer	1.21e-05	0.00112	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—RARB—cervical cancer	1.19e-05	0.0011	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—RARB—cervical cancer	1.17e-05	0.00108	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CA9—cervical cancer	1.17e-05	0.00108	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	1.17e-05	0.00108	CbGpPWpGaD
Progesterone—ABCC1—Disease—WNT5A—cervical cancer	1.16e-05	0.00107	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—AKAP13—cervical cancer	1.13e-05	0.00104	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—MTHFR—cervical cancer	1.11e-05	0.00102	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—TP53—cervical cancer	1.09e-05	0.001	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	1.08e-05	0.000991	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CA9—cervical cancer	1.06e-05	0.000974	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CA9—cervical cancer	1.06e-05	0.000973	CbGpPWpGaD
Progesterone—AR—Gene Expression—NOTCH2—cervical cancer	1.03e-05	0.000944	CbGpPWpGaD
Progesterone—ESR1—Generic Transcription Pathway—NOTCH1—cervical cancer	1.02e-05	0.000935	CbGpPWpGaD
Progesterone—NR3C1—Generic Transcription Pathway—NOTCH1—cervical cancer	1e-05	0.000921	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	9.85e-06	0.000907	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CA9—cervical cancer	9.85e-06	0.000906	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—WNT5A—cervical cancer	9.77e-06	0.000899	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CA9—cervical cancer	9.7e-06	0.000893	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—WNT2—cervical cancer	9.66e-06	0.000889	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	9.04e-06	0.000832	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NOTCH2—cervical cancer	8.75e-06	0.000806	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—AKAP13—cervical cancer	8.48e-06	0.000781	CbGpPWpGaD
Progesterone—PGR—Gene Expression—NOTCH1—cervical cancer	8.33e-06	0.000767	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—MTHFR—cervical cancer	8.16e-06	0.000751	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—NOTCH2—cervical cancer	7.9e-06	0.000727	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—NOTCH2—cervical cancer	7.78e-06	0.000716	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CA9—cervical cancer	7.65e-06	0.000704	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	7.46e-06	0.000686	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—WNT5A—cervical cancer	7.32e-06	0.000674	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CA9—cervical cancer	7.23e-06	0.000665	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	7.19e-06	0.000662	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HES1—cervical cancer	7.18e-06	0.000661	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NOTCH2—cervical cancer	6.86e-06	0.000631	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—MTHFR—cervical cancer	6.84e-06	0.000629	CbGpPWpGaD
Progesterone—ABCC1—Disease—HES1—cervical cancer	6.69e-06	0.000616	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CA9—cervical cancer	6.62e-06	0.00061	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—MTHFR—cervical cancer	6.55e-06	0.000603	CbGpPWpGaD
Progesterone—AR—Gene Expression—NOTCH1—cervical cancer	6.35e-06	0.000584	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TERT—cervical cancer	6.29e-06	0.000579	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CA9—cervical cancer	5.91e-06	0.000544	CbGpPWpGaD
Progesterone—ABCC1—Disease—MTHFR—cervical cancer	5.88e-06	0.000541	CbGpPWpGaD
Progesterone—ABCC1—Disease—TERT—cervical cancer	5.86e-06	0.00054	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CA9—cervical cancer	5.77e-06	0.000531	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—FGFR3—cervical cancer	5.77e-06	0.000531	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	5.69e-06	0.000524	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HES1—cervical cancer	5.62e-06	0.000517	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CA9—cervical cancer	5.44e-06	0.000501	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NOTCH1—cervical cancer	5.42e-06	0.000499	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CA9—cervical cancer	5.39e-06	0.000496	CbGpPWpGaD
Progesterone—ABCC1—Disease—FGFR3—cervical cancer	5.38e-06	0.000495	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NOTCH2—cervical cancer	5.14e-06	0.000473	CbGpPWpGaD
Progesterone—ABCC1—Disease—NOTCH1—cervical cancer	5.05e-06	0.000465	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TERT—cervical cancer	4.93e-06	0.000453	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—MTHFR—cervical cancer	4.92e-06	0.000453	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—NOTCH1—cervical cancer	4.89e-06	0.00045	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—NOTCH1—cervical cancer	4.82e-06	0.000443	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	4.78e-06	0.00044	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—MTHFR—cervical cancer	4.76e-06	0.000438	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CA9—cervical cancer	4.61e-06	0.000424	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—FGFR3—cervical cancer	4.52e-06	0.000416	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—MTHFR—cervical cancer	4.29e-06	0.000395	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—MTHFR—cervical cancer	4.29e-06	0.000395	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NOTCH1—cervical cancer	4.24e-06	0.000391	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HES1—cervical cancer	4.21e-06	0.000388	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MTOR—cervical cancer	4.06e-06	0.000374	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—MTHFR—cervical cancer	4e-06	0.000368	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—MTHFR—cervical cancer	3.94e-06	0.000362	CbGpPWpGaD
Progesterone—ABCC1—Disease—MTOR—cervical cancer	3.78e-06	0.000348	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—EGFR—cervical cancer	3.78e-06	0.000348	CbGpPWpGaD
Progesterone—ABCC1—Disease—CD4—cervical cancer	3.78e-06	0.000348	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CASP3—cervical cancer	3.73e-06	0.000344	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TERT—cervical cancer	3.69e-06	0.00034	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—CTNNB1—cervical cancer	3.6e-06	0.000331	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CA9—cervical cancer	3.56e-06	0.000327	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FGFR3—cervical cancer	3.39e-06	0.000312	CbGpPWpGaD
Progesterone—ABCC1—Disease—CTNNB1—cervical cancer	3.36e-06	0.000309	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NOTCH1—cervical cancer	3.18e-06	0.000293	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MTOR—cervical cancer	3.18e-06	0.000293	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—STAT3—cervical cancer	3.14e-06	0.000289	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—MTHFR—cervical cancer	3.1e-06	0.000286	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—MTHFR—cervical cancer	2.93e-06	0.00027	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CASP3—cervical cancer	2.92e-06	0.000269	CbGpPWpGaD
Progesterone—ABCC1—Disease—STAT3—cervical cancer	2.92e-06	0.000269	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—EGFR—cervical cancer	2.85e-06	0.000263	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—CTNNB1—cervical cancer	2.82e-06	0.00026	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—MTHFR—cervical cancer	2.69e-06	0.000247	CbGpPWpGaD
Progesterone—ABCC1—Disease—EGFR—cervical cancer	2.66e-06	0.000245	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—STAT3—cervical cancer	2.46e-06	0.000226	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—MTHFR—cervical cancer	2.4e-06	0.000221	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—cervical cancer	2.39e-06	0.00022	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MTOR—cervical cancer	2.38e-06	0.000219	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—MTHFR—cervical cancer	2.34e-06	0.000216	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—EGFR—cervical cancer	2.23e-06	0.000206	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—MTHFR—cervical cancer	2.21e-06	0.000203	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CASP3—cervical cancer	2.19e-06	0.000202	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—MTHFR—cervical cancer	2.19e-06	0.000201	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—CTNNB1—cervical cancer	2.11e-06	0.000194	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—cervical cancer	1.88e-06	0.000173	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—MTHFR—cervical cancer	1.87e-06	0.000172	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—STAT3—cervical cancer	1.84e-06	0.00017	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—EGFR—cervical cancer	1.67e-06	0.000154	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—MTHFR—cervical cancer	1.44e-06	0.000133	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—cervical cancer	1.41e-06	0.000129	CbGpPWpGaD
